ArticleJournal of the American Heart Association2026
Multimodal Machine Learning Integrating Clinical and Proteomic Data for Early Prediction of Hypertensive Complications: A UKB Longitudinal Study.
Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension is a leading risk factor for cardiovascular, cerebrovascular, and renal diseases, significantly worsening prognosis and quality of life. We aimed to develop and validate multimodal machine learning models integrating clinical and proteomic features for early prediction of hypertensive complications.
methodsWe analyzed 502 166 participants from the UKB (UK Biobank). Proteomic profiling was performed using the Olink Explore platform. Clinical variables and complication outcomes were obtained from electronic health records. Features were selected using Cox proportional hazards models and light gradient boosting machine classifiers. Multimodal predictive models were constructed using random forest, with Shapley Additive Explanations applied for model interpretation.
resultsDuring follow-up, 1232, 166, and 549 participants developed heart, brain, and kidney complications, respectively. Among 3244 candidate features, 774, 600, and 1227 were associated with these outcomes. The integrated models achieved an area under the curve of 0.73 (95% CI, 0.68-0.77) for heart disease, 0.83 (95% CI, 0.73-0.92) for brain disease, and 0.79 (95% CI, 0.73-0.85) for kidney disease. Growth/differentiation factor 15 (hazard ratio [HR], 2.16 [95% CI, 1.93-2.42]), adaptor protein 3 complex subunit σ-2 (HR, 0.57 [95% CI, 0.42-0.78]), and tumor necrosis factor receptor superfamily member 10B (HR, 4.06 [95% CI, 3.40-4.85]) were significantly associated with their respective complications, effectively predicting the risk of clinical progression (all
conclusionsMultimodal machine learning models combining proteomic and clinical data enable early identification of hypertensive complications. Growth/differentiation factor 15, adaptor protein 3 complex subunit σ-2, and tumor necrosis factor receptor superfamily member 10B may serve as potential biomarkers for risk prediction and early intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.